From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. HIV/AIDS Clinical Care>
  4. News in Context

HIV/AIDS Clinical Care: News in Context

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.


to
Items 21-30 of 46 are shown

One Pill, Once Daily: Now an Option for HIV Patients

The new (and long-awaited) tenofovir/FTC/efavirenz coformulation should be an effective option for treatment-naive patients, as well as for some treatment-experienced patients who want to reduce their pill burden.

  • By Paul E. Sax, MD
  • July 31, 2006

New Black Box Warning for Ritonavir-Boosted Tipranavir

Ritonavir-boosted tipranavir is associated with a very small risk of intracranial hemorrhage.

  • By Catherine Tomeo Ryan
  • July 11, 2006

Enrollment Halted in the SMART Study

During a median follow-up of 24 months, patients who were interrupting therapy regularly had a higher risk for disease progression than did those who maintained continuous therapy.

  • By ACC Editors
  • January 18, 2006

Trials of Aplaviroc Halted in Treatment-Naive Patients

On September 15, 2005, GlaxoSmithKline (GSK) announced that it had halted clinical trials of the CCR5 entry inhibitor, aplaviroc (GW873140), in HIV-infected, treatment-naive patients because . . .

  • By Catherine Tomeo Ryan
  • September 28, 2005

FDA Approves Generic AZT for U.S. Market

The FDA has approved the marketing in the U.S. of four generic formulations of AZT (zidovudine):

  • By Matthew O’Rourke
  • September 28, 2005

HIV Cases in the U.S. Exceed 1 Million

CDC officials reported at the National HIV Prevention Conference in June that there are now more than 1 million HIV-infected people in the U.S. — . . .

  • By ACC Editors
  • July 13, 2005

LGV Cases Reported in the U.S. and Europe

Lymphogranuloma venereum (LGV) is considered rare in the U.S. and Europe, but concerns have been raised recently about a possible resurgence among men who have . . .

  • By ACC Editors
  • July 13, 2005

Renewed Interest in Routine HIV Screening

On the heels of the recent publication of two large, well-designed modeling studies that showed routine HIV testing to be cost-effective under a variety of . . .

  • By Matthew O'Rourke
  • March 21, 2005

Drug-Induced Hepatitis with Saquinavir/Ritonavir + Rifampin

  • By ACC Editors
  • March 1, 2005

A Single Case of Multidrug-Resistant HIV and Rapid Disease Progression

  • By Matthew O'Rourke
  • March 1, 2005
Items 21-30 of 46 are shown

to

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?





Copyright © 2013. Massachusetts Medical Society. All rights reserved.